Danaher (NYSE:DHR) Price Target Lowered to $230.00 at Wolfe Research

Danaher (NYSE:DHR) had its price target reduced by stock analysts at Wolfe Research from $260.00 to $230.00 in a report released on Wednesday,MarketScreener reports. The firm presently has an “outperform” rating on the conglomerate’s stock. Wolfe Research’s target price suggests a potential upside of 16.98% from the company’s previous close.

Other equities research analysts have also issued reports about the company. The Goldman Sachs Group cut their price objective on Danaher from $270.00 to $265.00 and set a “buy” rating for the company in a research note on Thursday, January 29th. Argus set a $265.00 price objective on Danaher in a research note on Wednesday, January 14th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Leerink Partners boosted their price objective on Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Finally, Guggenheim boosted their price objective on Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a research note on Friday, January 2nd. Eighteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $251.35.

Danaher Stock Performance

Shares of DHR stock traded up $5.61 on Wednesday, hitting $196.62. The company had a trading volume of 163,691 shares, compared to its average volume of 4,015,473. The firm has a market cap of $139.14 billion, a P/E ratio of 38.90, a price-to-earnings-growth ratio of 2.59 and a beta of 0.95. The company has a 50-day moving average price of $202.70 and a 200-day moving average price of $214.59. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. Danaher has a twelve month low of $171.00 and a twelve month high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. The company had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.Danaher’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.14 EPS. As a group, equities research analysts predict that Danaher will post 7.63 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the transaction, the executive vice president directly owned 5,099 shares in the company, valued at $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.20% of the stock is owned by company insiders.

Institutional Trading of Danaher

Several hedge funds have recently modified their holdings of the stock. Osbon Capital Management LLC acquired a new stake in shares of Danaher in the fourth quarter valued at $49,000. World Investment Advisors increased its holdings in Danaher by 1.5% in the fourth quarter. World Investment Advisors now owns 13,931 shares of the conglomerate’s stock valued at $3,189,000 after buying an additional 211 shares during the last quarter. Winthrop Partners WNY LLC acquired a new stake in Danaher in the fourth quarter valued at $923,000. Union Savings Bank purchased a new stake in Danaher during the 4th quarter worth about $591,000. Finally, Storen Legacy Partners LLC acquired a new position in shares of Danaher during the 4th quarter worth about $3,359,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.